Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3)
Clinical trial NCT03795311 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03795311
- Sponsor
- Centre Georges Francois Leclerc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2023-01-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.